XORTX Therapeutics (XRTX) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-1.24
-0.81
-0.37
0.06

Details

Expected EPS
-0.383128
Actual EPS
-0.29
Surprise EPS
0.09
Surprise Percent
+24.31%

Description

XORTX Therapeutics (XRTX) has reported earnings of -0.29 per share for Q4 2024.

0 Comments

Share your thoughts